Mr. Stevenson serves as Executive Chairman of the Board of Directors of GeminiBio Products.
Most recently, Mr. Stevenson was the President of the BioProduction Division at Thermo Fisher Scientific (NYSE: TMO) (2008 – 2021), a division that Mr. Stevenson started. The business included a portfolio of products and services, including cell culture media, buffers, process liquids, purification resins, beads, single-use bio process containment, bioreactors, mixers, sera, and biopharma analytic assays. Mr. Stevenson’s division operated major domestic production facilities in New York, Massachusetts, and Utah and an international facility in the United Kingdom, with a commercial and application specialist team across the globe. Over Mr. Stevenson’s tenure, the division grew revenues from $200 million to over $2.5 billion annually and improved profitability every year. Prior to Thermo Fisher, Mr. Stevenson held positions with Pelican Life Science (2005-2008), US Oncology (2002-2005), and Fisher Scientific (1995-2002). Mr. Stevenson has a successful track record of developing proven and winning strategies, implementing better and more efficient processes and plans, and delivering robust business practices for long-term success.